April 01, 2026

Visual Snow Challenges Diagnosis

A case highlights persistent visual symptoms despite normal testing and suggests a neurofunctional origin.

Conexiant

April 01, 2026

Bipolar Psychosis: Examining Diagnostic Boundaries

Investigators synthesize schizophrenia comorbidity and psychotic symptom profiles across bipolar populations.

Conexiant

April 01, 2026

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Conexiant

March 31, 2026

Postzoster Neuralgia Linked to Tinnitus

Nationwide cohort analysis finds higher tinnitus incidence during long-term follow-up among patients with postzoster neuralgia, particularly older patients and certain comorbidities.

Conexiant

March 31, 2026

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

Conexiant

March 30, 2026

FDA Updates SMA Treatment Dosing

A higher-dose nusinersen regimen for spinal muscular atrophy demonstrated statistically significant motor function improvement in treatment-naïve infants in the DEVOTE trial with a safety profile consistent with prior dosing.

Conexiant

March 27, 2026

Meningococcal Abscess Detected by MRI

MRI identifies rare intracranial complication following normal computed tomography

Conexiant

March 26, 2026

Turning Baby Teeth Into Cell Therapy

SHED cells show early promise as a potential regenerative therapy in cerebral palsy research

The Medicine Maker

March 25, 2026

Tau Biomarker Expands Beyond Alzheimer’s

Study finds elevated phosphorylated tau in AL and ATTR amyloidosis, suggesting a potential blood biomarker for amyloid-related neuropathy

The Pathologist

March 23, 2026

MRI Identifies 3 Friedreich Ataxia Subtypes

Machine learning analysis of structural MRI reveals distinct patterns of neurodegeneration that vary in their association with disease severity

Conexiant